Transmedics Group Inc

Common Name

Transmedics Group

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

728

Ticker

TMDX

Exchange

NASDAQ/NMS

Website

www.transmedics.com

Description

TransMedics Group Inc. is a medical technology company focused on the commercialization of organ transplant therapy systems. The company has developed the Organ Care System (OCS), a transformative and... Show more

Financial Statements of Transmedics Group

Below are the financial statements of Transmedics Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash	336.65^a	394.81^a
Accounts receivable	97.72^a	63.58^a
Inventory	46.55^a	44.24^a
Prepaid expenses and other current assets	16.29^a	8.03^a
Total current assets	497.22^a	510.65^a
Assets	—	—
Property, plant and equipment, net	285.97^a	173.94^a
Operating lease right-of-use assets	6.48^a	6.55^a
Restricted cash	0.5^a	0.5^a
Goodwill	11.55^a	11.99^a
Acquired intangible assets, net	2.15^a	2.35^a
Other non-current assets	0.21^a	0.06^a
Total assets	804.08^a	706.05^a
Current liabilities	—	—
Accounts payable	10.29^a	12.72^a
Accrued expenses and other current liabilities	45.15^a	38.22^a
Deferred revenue	1.74^a	1.96^a
Operating lease liabilities	2.73^a	2.04^a
Total current liabilities	59.91^a	54.93^a
Liabilities and stockholders' equity	—	—
Convertible senior notes, net	449.94^a	447.14^a
Long-term debt, net	59.37^a	59.06^a
Operating lease liabilities, net of current portion	6.25^a	7.71^a
Total liabilities	575.47^a	568.85^a
Stockholders' equity	—	—
Preferred stock	0^a	0^a
Common stock	697.21^a	641.11^a
Accumulated other comprehensive loss	-0.36^a	-0.2^a
Accumulated deficit	-468.24^a	-503.71^a
Total stockholders' equity	228.6^a	137.2^a
Total liabilities and stockholders' equity	804.08^a	706.05^a

Verified Sources Behind Transmedics Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Transmedics Group’s data sources below and access millions more through our Disclosure Search.

a. Transmedics Group's 10-K 2024

Trace every data point back to Transmedics Group’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Transmedics Group Inc

Financial Statements of Transmedics Group

Verified Sources Behind Transmedics Group’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Penumbra Inc

Haemonetics Corp

Zimmer Biomet Holdings Inc

Stryker Corp

Procept Biorobotics Corp

Masimo Corp